We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04926831
Brief Title: Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC (Geometry-N)

First Submitted : June 14, 2021
First Submitted that Met QC Criteria : June 14, 2021
First Posted : June 15, 2021

Last Update Submitted that Met QC Criteria : October 5, 2022
Last Update Posted : October 6, 2022